Cite
HARVARD Citation
Andersen, O. et al. (2004). Multicentre, randomised, double blind, placebo controlled, phase III study of weekly, low dose, subcutaneous interferon beta-1a in secondary progressive multiple sclerosis. Journal of neurology, neurosurgery and psychiatry. 75 (5), pp. 706-710. [Online].